Royal Bank Of Canada Merck & Co., Inc. Put Options Transaction History

Royal Bank Of Canada

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2023 Aug 14, 2023	BUY	$108.61 - $118.38 $16.2 Million - $17.7 Million	149,400 Added 24900.0%	150,000 $17.3 Million
Q1 2023 May 15, 2023	SELL	$102.94 - $114.86 $49.9 Million - $55.6 Million	-484,300 Reduced 99.88%	600 $63,000
Q4 2022 Feb 14, 2023	BUY	$87.44 - $112.11 $35.4 Million - $45.4 Million	404,600 Added 503.86%	484,900 $53.8 Million
Q3 2022 Nov 14, 2022	BUY	$84.53 - $94.96 $363,479 - $408,328	4,300 Added 5.66%	80,300 $6.92 Million
Q1 2022 May 16, 2022	SELL	$73.51 - $82.4 $4.78 Million - $5.36 Million	-65,000 Reduced 46.1%	76,000 $6.24 Million
Q4 2021 Feb 14, 2022	BUY	$72.28 - $90.54 $1.52 Million - $1.9 Million	21,000 Added 17.5%	141,000 $10.8 Million
Q3 2021 Nov 15, 2021	BUY	$71.68 - $78.83 $5.38 Million - $5.91 Million	75,000 Added 166.67%	120,000 $9.01 Million
Q2 2021 Aug 16, 2021	BUY	$70.31 - $77.77 $3.16 Million - $3.5 Million	45,000 New	45,000 $3.5 Million

3,824

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $255B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.